-
Evaluating the impact of instrumental variables in propensity score models using synthetic and negative control experiments
Authors:
Yuxi Tian,
Nicole Pratt,
Laura L Hester,
George Hripcsak,
Martijn J Schuemie,
Marc A Suchard
Abstract:
In pharmacoepidemiology research, instrumental variables (IVs) are variables that strongly predict treatment but have no causal effect on the outcome of interest except through the treatment. There remain concerns about the inclusion of IVs in propensity score (PS) models amplifying estimation bias and reducing precision. Some PS modeling approaches attempt to address the potential effects of IVs,…
▽ More
In pharmacoepidemiology research, instrumental variables (IVs) are variables that strongly predict treatment but have no causal effect on the outcome of interest except through the treatment. There remain concerns about the inclusion of IVs in propensity score (PS) models amplifying estimation bias and reducing precision. Some PS modeling approaches attempt to address the potential effects of IVs, including selecting only covariates for the PS model that are strongly associated to the outcome of interest, thus screening out IVs. We conduct a study utilizing simulations and negative control experiments to evaluate the effect of IVs on PS model performance and to uncover best PS practices for real-world studies. We find that simulated IVs have a weak effect on bias and precision in both simulations and negative control experiments based on real-world data. In simulation experiments, PS methods that utilize outcome data, including the high-dimensional propensity score, produce the least estimation bias. However, in real-world settings underlying causal structures are unknown, and negative control experiments can illustrate a PS model's ability to minimize systematic bias. We find that large-scale, regularized regression based PS models in this case provide the most centered negative control distributions, suggesting superior performance in real-world scenarios.
△ Less
Submitted 21 March, 2024;
originally announced March 2024.
-
Efficient GPU-accelerated fitting of observational health-scaled stratified and time-varying Cox models
Authors:
Jianxiao Yang,
Martijn J. Schuemie,
Marc A. Suchard
Abstract:
The Cox proportional hazards model stands as a widely-used semi-parametric approach for survival analysis in medical research and many other fields. Numerous extensions of the Cox model have further expanded its versatility. Statistical computing challenges arise, however, when applying many of these extensions with the increasing complexity and volume of modern observational health datasets. To a…
▽ More
The Cox proportional hazards model stands as a widely-used semi-parametric approach for survival analysis in medical research and many other fields. Numerous extensions of the Cox model have further expanded its versatility. Statistical computing challenges arise, however, when applying many of these extensions with the increasing complexity and volume of modern observational health datasets. To address these challenges, we demonstrate how to employ massive parallelization through graphics processing units (GPU) to enhance the scalability of the stratified Cox model, the Cox model with time-varying covariates, and the Cox model with time-varying coefficients. First we establish how the Cox model with time-varying coefficients can be transformed into the Cox model with time-varying covariates when using discrete time-to-event data. We then demonstrate how to recast both of these into a stratified Cox model and identify their shared computational bottleneck that results when evaluating the now segmented partial likelihood and its gradient with respect to regression coefficients at scale. These computations mirror a highly transformed segmented scan operation. While this bottleneck is not an immediately obvious target for multi-core parallelization, we convert it into an un-segmented operation to leverage the efficient many-core parallel scan algorithm. Our massively parallel implementation significantly accelerates model fitting on large-scale and high-dimensional Cox models with stratification or time-varying effect, delivering an order of magnitude speedup over traditional central processing unit-based implementations.
△ Less
Submitted 24 October, 2023;
originally announced October 2023.
-
Bayesian Safety Surveillance with Adaptive Bias Correction
Authors:
Fan Bu,
Martijn J. Schuemie,
Akihiko Nishimura,
Louisa H. Smith,
Kristin Kostka,
Thomas Falconer,
Jody-Ann McLeggon,
Patrick B. Ryan,
George Hripcsak,
Marc A. Suchard
Abstract:
Post-market safety surveillance is an integral part of mass vaccination programs. Typically relying on sequential analysis of real-world health data as they accrue, safety surveillance is challenged by the difficulty of sequential multiple testing and by biases induced by residual confounding. The current standard approach based on the maximized sequential probability ratio test (MaxSPRT) fails to…
▽ More
Post-market safety surveillance is an integral part of mass vaccination programs. Typically relying on sequential analysis of real-world health data as they accrue, safety surveillance is challenged by the difficulty of sequential multiple testing and by biases induced by residual confounding. The current standard approach based on the maximized sequential probability ratio test (MaxSPRT) fails to satisfactorily address these practical challenges and it remains a rigid framework that requires pre-specification of the surveillance schedule. We develop an alternative Bayesian surveillance procedure that addresses both challenges using a more flexible framework. We adopt a joint statistical modeling approach to sequentially estimate the effect of vaccine exposure on the adverse event of interest and correct for estimation bias by simultaneously analyzing a large set of negative control outcomes through a Bayesian hierarchical model. We then compute a posterior probability of the alternative hypothesis via Markov chain Monte Carlo sampling and use it for sequential detection of safety signals. Through an empirical evaluation using six US observational healthcare databases covering more than 360 million patients, we benchmark the proposed procedure against MaxSPRT on testing errors and estimation accuracy, under two epidemiological designs, the historical comparator and the self-controlled case series. We demonstrate that our procedure substantially reduces Type 1 error rates, maintains high statistical power, delivers fast signal detection, and provides considerably more accurate estimation. As an effort to promote open science, we present all empirical results in an R ShinyApp and provide full implementation of our method in the R package EvidenceSynthesis.
△ Less
Submitted 19 May, 2023;
originally announced May 2023.
-
Adjusting for both sequential testing and systematic error in safety surveillance using observational data: Empirical calibration and MaxSPRT
Authors:
Martijn J. Schuemie,
Fan Bu,
Akihiko Nishimura,
Marc A. Suchard
Abstract:
Post-approval safety surveillance of medical products using observational healthcare data can help identify safety issues beyond those found in pre-approval trials. When testing sequentially as data accrue, maximum sequential probability ratio testing (MaxSPRT) is a common approach to maintaining nominal type 1 error. However, the true type 1 error may still deviate from the specified one because…
▽ More
Post-approval safety surveillance of medical products using observational healthcare data can help identify safety issues beyond those found in pre-approval trials. When testing sequentially as data accrue, maximum sequential probability ratio testing (MaxSPRT) is a common approach to maintaining nominal type 1 error. However, the true type 1 error may still deviate from the specified one because of systematic error due to the observational nature of the analysis. This systematic error may persist even after controlling for known confounders. Here we propose to address this issue by combing MaxSPRT with empirical calibration. In empirical calibration, we assume uncertainty about the systematic error in our analysis, the source of uncertainty commonly overlooked in practice. We infer a probability distribution of systematic error by relying on a large set of negative controls: exposure-outcome where no causal effect is believed to exist. Integrating this distribution into our test statistics has previously been shown to restore type 1 error to nominal. Here we show how we can calibrate the critical value central to MaxSPRT. We evaluate this novel approach using simulations and real electronic health records, using H1N1 vaccinations during the 2009-2010 season as an example. Results show that combining empirical calibration with MaxSPRT restores nominal type 1 error. In our real-world example, adjusting for systematic error using empirical calibration has a larger impact than, and hence is just as essential as, adjusting for sequential testing using MaxSPRT. We recommend performing both, using the method described here.
△ Less
Submitted 6 July, 2022;
originally announced July 2022.
-
Massive Parallelization of Massive Sample-size Survival Analysis
Authors:
Jianxiao Yang,
Martijn J. Schuemie,
Xiang Ji,
Marc A. Suchard
Abstract:
Large-scale observational health databases are increasingly popular for conducting comparative effectiveness and safety studies of medical products. However, increasing number of patients poses computational challenges when fitting survival regression models in such studies. In this paper, we use graphics processing units (GPUs) to parallelize the computational bottlenecks of massive sample-size s…
▽ More
Large-scale observational health databases are increasingly popular for conducting comparative effectiveness and safety studies of medical products. However, increasing number of patients poses computational challenges when fitting survival regression models in such studies. In this paper, we use graphics processing units (GPUs) to parallelize the computational bottlenecks of massive sample-size survival analyses. Specifically, we develop and apply time- and memory-efficient single-pass parallel scan algorithms for Cox proportional hazards models and forward-backward parallel scan algorithms for Fine-Gray models for analysis with and without a competing risk using a cyclic coordinate descent optimization approach. We demonstrate that GPUs accelerate the computation of fitting these complex models in large databases by orders of magnitude as compared to traditional multi-core CPU parallelism. Our implementation enables efficient large-scale observational studies involving millions of patients and thousands of patient characteristics. The above implementation is available in the open-source R package Cyclops (Suchard et al., 2013).
△ Less
Submitted 9 May, 2023; v1 submitted 18 April, 2022;
originally announced April 2022.
-
Combining Cox Regressions Across a Heterogeneous Distributed Research Network Facing Small and Zero Counts
Authors:
Martijn J. Schuemie,
Yong Chen,
David Madigan,
Marc A. Suchard
Abstract:
Studies of the effects of medical interventions increasingly take place in distributed research settings using data from multiple clinical data sources including electronic health records and administrative claims. In such settings, privacy concerns typically prohibit sharing of individual patient data, and instead, analyses can only utilize summary statistics from the individual databases. In the…
▽ More
Studies of the effects of medical interventions increasingly take place in distributed research settings using data from multiple clinical data sources including electronic health records and administrative claims. In such settings, privacy concerns typically prohibit sharing of individual patient data, and instead, analyses can only utilize summary statistics from the individual databases. In the specific but very common context of the Cox proportional hazards model, we show that standard meta analysis methods then lead to substantial bias when outcome counts are small. This bias derives primarily from the normal approximations that the methods utilize. Here we propose and evaluate methods that eschew normal approximations in favor of three more flexible approximations: a skew-normal, a one-dimensional grid, and a custom parametric function that mimics the behavior of the Cox likelihood function. In extensive simulation studies we demonstrate how these approximations impact bias in the context of both fixed-effects and (Bayesian) random-effects models. We then apply these approaches to three real-world studies of the comparative safety of antidepressants, each using data from four observational healthcare databases.
△ Less
Submitted 5 January, 2021;
originally announced January 2021.
-
A systematic approach to improving the reliability and scale of evidence from health care data
Authors:
Martijn J. Schuemie,
Patrick B. Ryan,
George Hripcsak,
David Madigan,
Marc A. Suchard
Abstract:
Concerns over reproducibility in science extend to research using existing healthcare data; many observational studies investigating the same topic produce conflicting results, even when using the same data. To address this problem, we propose a paradigm shift. The current paradigm centers on generating one estimate at a time using a unique study design with unknown reliability and publishing (or…
▽ More
Concerns over reproducibility in science extend to research using existing healthcare data; many observational studies investigating the same topic produce conflicting results, even when using the same data. To address this problem, we propose a paradigm shift. The current paradigm centers on generating one estimate at a time using a unique study design with unknown reliability and publishing (or not) one estimate at a time. The new paradigm advocates for high-throughput observational studies using consistent and standardized methods, allowing evaluation, calibration, and unbiased dissemination to generate a more reliable and complete evidence base. We demonstrate this new paradigm by comparing all depression treatments for a set of outcomes, producing 17,718 hazard ratios, each using methodology on par with state-of-the-art studies. We furthermore include control hypotheses to evaluate and calibrate our evidence generation process. Results show good transitivity and consistency between databases, and agree with four out of the five findings from clinical trials. The distribution of effect size estimates reported in literature reveals an absence of small or null effects, with a sharp cutoff at p = 0.05. No such phenomena were observed in our results, suggesting more complete and more reliable evidence.
△ Less
Submitted 28 March, 2018;
originally announced March 2018.
-
A Concept Annotation System for Clinical Records
Authors:
Ning Kang,
Rogier Barendse,
Zubair Afzal,
Bharat Singh,
Martijn J. Schuemie,
Erik M. van Mulligen,
Jan A. Kors
Abstract:
Unstructured information comprises a valuable source of data in clinical records. For text mining in clinical records, concept extraction is the first step in finding assertions and relationships. This study presents a system developed for the annotation of medical concepts, including medical problems, tests, and treatments, mentioned in clinical records. The system combines six publicly available…
▽ More
Unstructured information comprises a valuable source of data in clinical records. For text mining in clinical records, concept extraction is the first step in finding assertions and relationships. This study presents a system developed for the annotation of medical concepts, including medical problems, tests, and treatments, mentioned in clinical records. The system combines six publicly available named entity recognition system into one framework, and uses a simple voting scheme that allows to tune precision and recall of the system to specific needs. The system provides both a web service interface and a UIMA interface which can be easily used by other systems. The system was tested in the fourth i2b2 challenge and achieved an F-score of 82.1% for the concept exact match task, a score which is among the top-ranking systems. To our knowledge, this is the first publicly available clinical record concept annotation system.
△ Less
Submitted 7 December, 2010;
originally announced December 2010.
